SECsense Logo

Omega Therapeutics, Inc. 8-K Report: Key Insights and Stock Info

$OMGA
Form 8-K
Filed on: 2025-02-14
Source
Omega Therapeutics, Inc. 8-K Report: Key Insights and Stock Info

Here are the key insights extracted from the provided section of the financial report:

  1. Entity Information:
  • Company Name: Omega Therapeutics, Inc.
  • CIK: 0001850838 (Central Index Key used by the SEC)
  • SEC File Number: 001-40657
  • EIN: 81-3247585 (Employer Identification Number)
  1. Address:
  • Location: 140 First Street, Suite 501, Cambridge, MA 02141
  • Phone Number: (617) 949-4360
  1. Stock Information:
  • Common Stock: Par value of $0.001 per share
  • Ticker Symbol: OMGA
  • Exchange: NASDAQ
  1. Filing Information:
  • Filing Type: 8-K (used to report major events that shareholders should know about)
  • Filing Date: February 10, 2025
  1. Reporting Period:
  • Start Date: February 10, 2025
  • End Date: February 10, 2025
  1. XBRL Context:
  • This report is formatted in XBRL (eXtensible Business Reporting Language) which is used for electronic submission of financial data.

These points summarize the essential details related to Omega Therapeutics, Inc. as presented in the financial report. This information is crucial for investors and analysts to evaluate the company’s status and recent activities.